2013
Association of osteprotegerin, bone turnover, and bone loss after adjuvant chemotherapy in early-stage breast cancer.
Oostra D, Lustberg M, Pan X, Shapiro C. Association of osteprotegerin, bone turnover, and bone loss after adjuvant chemotherapy in early-stage breast cancer. Journal Of Clinical Oncology 2013, 31: 134-134. DOI: 10.1200/jco.2013.31.26_suppl.134.Peer-Reviewed Original ResearchBone mineral densityFollicle stimulating hormoneEarly-stage breast cancerRapid bone lossBreast cancerBone lossAdjuvant chemotherapyFemoral neckBone resorptionLumbar spineStage ILS bone mineral densityCompensatory responseNegative pregnancy testMonth time pointSubsequent bone resorptionOPG increasePremenopausal womenBone healthBone turnoverMIU/Osteoclast activationMineral densityStimulating hormonePregnancy test
2012
Bone Health in Adult Cancer Survivorship
Lustberg M, Reinbolt R, Shapiro C. Bone Health in Adult Cancer Survivorship. Journal Of Clinical Oncology 2012, 30: 3665-3674. PMID: 23008309, DOI: 10.1200/jco.2012.42.2097.Peer-Reviewed Original ResearchConceptsBone lossOsteoporotic fracture riskCancer treatmentCancer survivorsChemotherapy-induced ovarian failureGonadotropin-releasing hormone agonistDual-energy X-ray absorptiometryFracture assessment toolAndrogen deprivation therapyBone mineral density measurementsVitamin D supplementationMonoclonal antibody therapyLack of exerciseX-ray absorptiometryMineral density measurementsAdult cancer survivorshipHealthy bone remodelingBisphosphonate therapyD supplementationDeprivation therapySurgical oophorectomyAntibody therapyBone healthHormone agonistOsteoporotic fractures